Daniel M. Rotroff, PhD of @CleClinicMD discusses the response to anti-PD-1/PD-L1 antibody immunotherapy.
__________
Read here: https://ascopubs.org/doi/full/10.1200/JCO.19.01712
Latest Videos
Daneng Li, MD on GAIN: What are the Differences Between the Studies? @DanengLi #ASCO @cityofhope #ASCO2020
Daneng Li, MD on GAIN: Chemotherapy Toxicity in Older Adults with Cancer @DanengLi #ASCO @cityofhope #ASCO2020
Robert Epstein, MD, MS on Chemotherapy-Induced Myelosuppression: Is the Issue the Same? #ASCO2020 #ASCO
